clinical trial · NCT04508530
Phase III Study To Compare The Effect of Panzyga Versus Placebo in Patients With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS/PANDAS)
Octapharma·phase3·completed·n = 71
Pediatric Acute-Onset Neuropsychiatric SyndromePanzygaPlacebo
brief summary
A Superiority Study To Compare The Effect of Panzyga Versus Placebo in Patients with Pediatric Acute-onset Neuropsychiatric Syndrome
started
Jun 30, 2021
primary completion
Aug 27, 2024
completion
Oct 30, 2024
last updated
Jan 7, 2026
official title
A Superiority Phase III Study To Compare The Effect of Panzyga Versus Placebo in Patients With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS/PANDAS)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol